Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Compumedics Limited

Market Cap 47.94M 33.81M 29.21M 26.91M 25.19M 47.21M 3.21B 318M 124M 1.56B 127M 124M 5.42B P/E Ratio 2026 *
16x
P/E Ratio 2027 * 6.49x
Enterprise Value 47.94M 33.81M 29.21M 26.91M 25.19M 47.21M 3.21B 318M 124M 1.56B 127M 124M 5.42B EV / Sales 2026 *
0.72x
EV / Sales 2027 * 0.6x
Free-Float
36.04%
Yield 2026 *
-
Yield 2027 * 8.33%
1 day-2.04%
1 week-5.88%
Current month-11.11%
1 month-14.29%
3 months-21.31%
6 months-30.43%
Current year-28.36%
1 week 0.24
Extreme 0.24
0.26
1 month 0.24
Extreme 0.24
0.28
Current year 0.24
Extreme 0.24
0.45
1 year 0.24
Extreme 0.24
0.45
3 years 0.15
Extreme 0.15
0.45
5 years 0.14
Extreme 0.135
0.49
10 years 0.14
Extreme 0.135
0.96
Manager TitleAgeSince
Chief Executive Officer 67 16/12/2010
Director of Finance/CFO 61 11/11/2009
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 67 16/12/2010
Director/Board Member 61 01/01/2000
Director/Board Member - 27/10/2022
Change 5-day change 1-year change 3-year change Capi.($)
-2.04%-5.88%-12.73%+20.00% 33.81M
-1.33%-0.73%+16.53%-10.78% 174B
-0.45%-2.61%-19.74%+30.31% 146B
-0.38%-2.28%-10.25%-25.35% 127B
-0.55%-3.38%-52.97%-8.31% 69.72B
-0.76%-0.99%+13.25%-2.62% 49.01B
+0.67%-0.60%-24.14%-34.78% 44.74B
+0.22%-4.13%+10.90%+8.65% 36.67B
-1.17%-2.69%+3.87%+35.04% 34.91B
+1.04%+0.79%-9.79%-16.21% 29.65B
Average -0.48%-2.47%-8.51%-0.40% 71.22B
Weighted average by Cap. -0.55%-1.98%-7.27%-2.67%

Financials

2026 *2027 *
Net sales 66.3M 46.76M 40.39M 37.22M 34.84M 65.29M 4.44B 439M 171M 2.16B 176M 172M 7.49B 79.7M 56.21M 48.55M 44.74M 41.88M 78.48M 5.34B 528M 206M 2.6B 211M 206M 9B
Net income 3.8M 2.68M 2.31M 2.13M 2M 3.74M 255M 25.19M 9.82M 124M 10.06M 9.84M 429M 9M 6.35M 5.48M 5.05M 4.73M 8.86M 603M 59.66M 23.26M 294M 23.82M 23.32M 1.02B
Net Debt - -
Logo Compumedics Limited
Compumedics Limited is an Australia-based medical device company which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications. Its geographic segments include the Americas, Australia and Asia Pacific, and Europe and the Middle East. It sells all of its product offerings in this region, including sleep diagnostic systems, clinical electroencephalograms (EEG systems), brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. It provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. It provides a range of solutions for the neurology laboratory, from clinical epilepsy monitoring applications to Transcranial Doppler Sonography. Its other products include Grael 4K PSG, Falcon HST, Okti, Neuvo 64-512 Channel LTM EEG and others.
Employees
175
Date Price Change Volume
12/06/26 0.2400 $ -2.04% 46,493
11/06/26 0.2450 $ -2.00% 47,976
10/06/26 0.2500 $ 0.00% 43,562
09/06/26 0.2500 $ -1.96% 17,161
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2400AUD
Average target price
0.8000AUD
Spread / Average Target
+233.33%

Annual profits - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!